Showing 13,561 - 13,570 of 13,868
The autumn forecast for Swiss health expenditure covers the years 2008 to 2011 (official data range to 2007). For the year 2008, the forecast assumes a higher-than-average growth in health expenditure. While a still solid growth is expected for the year 2009, a cooling down as a consequence of...
Persistent link: https://www.econbiz.de/10010280853
The spring forecast for Swiss health expenditure covers the years 2008 to 2010 (official data range to 2007). For the year 2008, the forecast assumes a higher-than-average growth in health expenditure. While a still solid growth is expected for the year 2009, a cooling down as a consequence of...
Persistent link: https://www.econbiz.de/10010280856
Publicly provided health care implies considerable intergenerational redistribution. The possibility of accumulating a fund or debt will affect the degree of redistribution as well as how efficient the financing of health care is. In a voting model we study how governments inability to make...
Persistent link: https://www.econbiz.de/10010281239
There are few studies investigating the consequences of osteoporotic (low bone density) fractures in terms of costs and health outcomes. The purpose of this Swedish pilot study is to assess the costs and quality of life related to fractures of the hip, spine, wrist and shoulder and further to...
Persistent link: https://www.econbiz.de/10010281361
Women's rights and economic development are highly correlated. Today, the discrepancy between the legal rights of women and men is much larger in developing compared to developed countries. Historically, even in countries that are now rich women had few rights before economic development took...
Persistent link: https://www.econbiz.de/10010282336
This paper analyzes possible justifications for government interventions in health and old age insurance and illustrates the theoretical considerations by the case of Chile where a comprehensive social sector reform took place in the 1980s. It is shown that health insurances can suffer from...
Persistent link: https://www.econbiz.de/10010283002
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is estimated to have increased mean age at death by...
Persistent link: https://www.econbiz.de/10010283600
This paper examines the impact of changes in poverty and public health spending on inter-temporal variations in longevity using a unique regional-level dataset that covers 77 regions of Russia over the period 1994-2000. The dynamic panel data model is used as a tool for the empirical analysis....
Persistent link: https://www.econbiz.de/10010284857
A large body of both theoretical and empirical literature has affirmed a positive impact of human capital accumulation in the form of health on economic growth. Yet Baumol (1967) has presented a model in which imbalances in productivity growth between a progressive (manufacturing) sector and a...
Persistent link: https://www.econbiz.de/10010285807
In this paper, we address the issue of spurious correlation in the production of health in a systematic way. Spurious correlation entails the risk of linking health status to medical (and nonmedical) inputs when no links exist. This note first presents the bounds testing procedure as a method to...
Persistent link: https://www.econbiz.de/10010285825